A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice

被引:67
作者
Alejandro Vasquez
Nader Atallah-Yunes
Frank C. Smith
Xiaomang You
Sharon E. Chase
Allen E. Silverstone
Karen L. Vikstrom
机构
[1] Department of Pharmacology, SUNY Upstate Medical University, Syracuse
[2] Department of Pediatrics, SUNY Upstate Medical University, Syracuse
[3] Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse
关键词
Aryl hydrocarbon receptor; Cardiomyocyte; Cardiomyopathy; Hypertrophy; Tobacco smoke;
D O I
10.1385/CT:3:2:153
中图分类号
学科分类号
摘要
The aryl hydrocarbon receptor (AhR), a ligand activated transcription factor, is the receptor for the polycyclic aromatic hydrocarbons found in tobacco smoke, polychlorinated biphenyls, and the environmental pollutant, dioxin. To better understand the role of the AhR in the heart, echocardiography, invasive measurements of aortic and left ventricular pressures, isolated working heart preparations, as well as morphological and molecular analysis were used to investigate the impact of AhR inactivation on the mouse heart using the AhR knockout as a model. Cardiac hypertrophy is an early phenotypic manifestation of the AhR knockout. Although the knockout animals were not hypertensive at the ages examined, cardiomyopathy accompanied by diminished cardiac output developed. Despite the structural left ventricular remodeling, the hearts of these animals exhibit minimal fibrosis and do not have the expected increases in surrogate molecular markers of cardiac hypertrophy. The anatomic remodeling without typical features of molecular remodeling is not consistent with hypertrophic growth secondary to pressure or volume overload, suggesting that increased cardiomyocyte size may be a direct consequence of the absence of the AhR in this cell type. © Copyright 2003 by Humana Press Inc. All rights of any nature whatsoever reserved.
引用
收藏
页码:153 / 163
页数:10
相关论文
共 54 条
[1]  
Lofroth G., Rannug A., Ah receptor ligands in tobacco smoke, Toxicol. Lett., 42, pp. 131-136, (1988)
[2]  
Rowlands J.C., Gustafsson J.A., Aryl hydrocarbon receptor-mediated signal transduction, Crit. Rev. Toxicol., 27, pp. 109-134, (1997)
[3]  
Savouret J.F., Antenos M., Quesne M., Xu J., Milgrom E., Casper R.F., 7-Ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor, J. Biol. Chem., 276, pp. 3054-3059, (2001)
[4]  
Sinal C.J., Bend J.R., Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatoma Hepa 1c1c7 cells, Mol. Pharmacol., 52, pp. 590-599, (1997)
[5]  
Phelan D., Winter G.M., Rogers W.J., Lam J.C., Denison M.S., Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin, Arch. Biochem. Biophys., 357, pp. 155-163, (1998)
[6]  
Seidel S.D., Winters G.M., Rogers W.J., Ziccardi M.H., Li V., Keser B., Denison M.S., Activation of the Ah receptor signaling pathway by prostaglandins, J. Biochem. Mol. Toxicol., 15, pp. 187-196, (2001)
[7]  
Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., Savouret J.F., Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity, Mol. Pharmacol., 56, pp. 784-790, (1999)
[8]  
Ciolino H.P., Yeh G.C., Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol, Mol. Pharmacol., 56, pp. 760-767, (1999)
[9]  
Williams S.N., Shih H., Guenette D.K., Brackney W., Denison M.S., Pickwell G.V., Quattrochi L.C., Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression, Chem. Biol. Interactions, 128, pp. 211-229, (2000)
[10]  
Song J., Clagett-Dame M., Peterson R.E., Hahn M.E., Westler W.M., Sicinski R.R., DeLuca H.F., A ligand for the aryl hydrocarbon receptor isolated from lung, Proc. Natl. Acad. Sci. USA, 99, pp. 14694-14699, (2002)